Volume 6, Issue 4 (Nov 2018)                   Res Mol Med (RMM) 2018, 6(4): 59-68 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Boroumand N, Eshaghiyan A, Behshood P, Nateghi B, Emadi F. Increased Circulating miR-10a Levels Associated with Multiple Sclerosis. Res Mol Med (RMM). 2018; 6 (4) :59-68
1- Department of Biotechnology, Faculty of Advanced Sciences and Technologies, University of Isfahan, Isfahan, Iran.
2- Department of Genetics, Arsanjan Branch, Islamic Azad University, Arsanjan, Shiraz, Iran.
3- Department of Microbiology, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
4- Department of Biochemistry, Faculty of Science, Nourdanesh Institutions of Higher Education, Meimeh, Isfahan, Iran.
5- Department of Genetics, Arsanjan Branch, Islamic Azad University, Arsanjan, Shiraz, Iran. ,
Abstract:   (2632 Views)
Background: Multiple sclerosis (MS) is an autoimmune disease that causes chronic inflammation of the central nervous system. MicroRNAs (miRNAs) are small non-coding RNAs 19–24 nucleotides long, which are differentially expressed in different tissues. The role of miRNAs in MS remains unclear. We assessed miR-10a transcript levels in MS patients during recurrence and two months after relapse.
Materials and methods: In this case-control study, we used real-time PCR to examine miR-10a expression in the peripheral blood mononuclear cells of 60 patients with relapsing-remitting multiple sclerosis (RRMS), 30 during recurrence and 30 two months after relapse, and 30 healthy subjects who were referred to the MS Clinic of Kashani Hospital, Isfahan Province. In silico analysis was also performed on the validated miR-10a targets using miRTarBase.
Results: miR-10a expression was higher in RRMS patients during recurrence and two months after relapse (p < 0.0001 and p < 0.0001, respectively) than in the healthy subjects. Furthermore, in silico molecular signaling enrichment analysis identified 12 mRNAs as validated miR-10a targets.
Conclusion: The expression of miR-10a was elevated in patients with RRMS compared to healthy subjects, suggesting that miR-10a could be a potential biomarker for RRMS diagnosis.
Full-Text [PDF 329 kb]   (467 Downloads)    
Type of Study: Research | Subject: Immunology
Received: 2019/03/12 | Published: 2018/11/15

Add your comments about this article : Your username or Email:

© 2021 CC BY-NC 4.0 | Research in Molecular Medicine

Designed & Developed by : Yektaweb